457
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

A study on the role of trust factor in adopting personalised medicine

, &
Pages 771-787 | Received 31 Mar 2017, Accepted 26 Apr 2019, Published online: 14 May 2019

References

  • Ahern, D. K., J. M. Kreslake, and J. M. Phalen. 2006. “What is E-Health (6): Perspectives on the Evolution of E-Health Research.” Journal of Medical Internet Research 8 (1): e4.
  • Andrews, G., and N. Titov. 2010. “Treating People You Never See: Internet Based Treatment of the Internalising Mental Disorders.” Australian Health Review 34 (2): 144–147.
  • Bagozzi, R. P., and Y. Yi. 1988. “On the Evaluation of Structural Equation Models.” Journal of the Academy of Marketing Science 16 (1): 74–94.
  • Baron, R. M., and D. A. Kenny. 1986. “The Moderator–Mediator Variable Distinction in Social Psychological Research: Conceptual, Strategic, and Statistical Considerations.” Journal of Personality and Social Psychology 51 (6): 1173.
  • Bennett, K., A. J. Bennett, and K. M. Griffiths. 2010. “Security Considerations for E-Mental Health Interventions.” Journal of Medical Internet Research 12 (5): e61.
  • Blobel, B., D. M. Lopez, and C. Gonzalez. 2016. “Patient Privacy and Security Concerns on Big Data for Personalized Medicine.” Health and Technology 6 (1): 75–81.
  • Bolouri, H. 2010. Personal Genomics and Personalized Medicine. London: Imperial College Press.
  • Bonow, R. O., B. A. Carabello, K. Chatterjee, A. C. De_Leon, D. P. Faxon, and M. D. Freed. 2006. “ACC/AHA 2006 Guidelines for the Management of Patients with Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease) Developed in Collaboration with the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons.” Journal of the American College of Cardiology 48 (3): 1–148.
  • Chang, I. C., H. G. Hwang, M. C. Hung, K. M. Kuo, and D. C. Yen. 2009. “Factors Affecting Cross-Hospital Exchange of Electronic Medical Records.” Information & Management 46 (2): 109–115.
  • Chimonas, S., N. J. DeVito, and D. J. Rothman. 2017. “Bringing Transparency to Medicine: Exploring Physicians’ Views and Experiences of the Sunshine Act.” The American Journal of Bioethics 17 (6): 4–18.
  • Chin, W. W. 1998. The Partial Least Squares Approach to Structural Equation Modeling. Modern Methods for Business Research 295: 295–336.
  • Clarke, A., and K. J. Thirlaway. 2011. “Genetic Counselling for Personalized Medicine.” Human Genetics 130: 27–31.
  • Cong, L., F. A. Ran, D. Cox, S. Lin, R. Barretto, N. Habib, and F. Zhang. 2013. “Multiplex Genome Engineering Using CRISPR/Cas Systems.” Science 339 (6121): 819–823.
  • Dreyfuss, J. M., D. Levner, J. E. Galagan, G. M. Church, and M. F. Ramoni. 2012. “How Accurate Can Genetic Predictions Be?” BMC Genomics 13 (1): 340.
  • Ehrenberg, A. S. C. 1976. Factor Analysis: Limitations and Alternatives. Cambridge, MA: Marketing Science Inst.
  • Erickson, J., and S. Millar. 2005. “Caring for Patients While Respecting Their Privacy: Renewing Our Commitment.” Online Journal of Issues in Nursing 10 (2).
  • Esvelt, K. M., and H. H. Wang. 2013. “Genome-Scale Engineering for Systems and Synthetic Biology.” Molecular Systems Biology 9 (1): 641.
  • Eysenbach, G. 2001. “What is E-Health?” Journal of Medical Internet Research 3 (2): e20.
  • Flavián, C., and M. Guinalíu. 2006. “Consumer Trust, Perceived Security and Privacy Policy: Three Basic Elements of Loyalty to a Web Site.” Industrial Management & Data Systems 106 (5): 601–620.
  • Fritz, Z., and R. Holton. 2018. “Too Much Medicine: Not Enough Trust?” Journal of Medical Ethics, Medethics 45: 31–35.
  • Galford, R., and A. S. Drapeau. 2003. “The Enemies of Trust.” Harvard Business Review 81 (2): 88–95.
  • Gefen, D., D. Straub, and M. C. Boudreau. 2000. “Structural Equation Modeling and Regression: Guidelines for Research Practice.” Communications of the Association for Information Systems 4 (1): 7.
  • Ginsburg, G. S., and J. J. McCarthy. 2001. “Personalized Medicine: Revolutionizing Drug Discovery and Patient Care.” TRENDS in Biotechnology 19 (12): 491–496.
  • Gunasekaran, A., and P. E. D. Love. 1999. “Current and Future Directions of Multimedia Technology in Business.” International Journal of Information Management 19 (2): 105–120.
  • Gurwitz, D., A. Weizman, and M. Rehavi. 2003. “Education: Teaching Pharmacogenomics to Prepare Future Physicians and Researchers for Personalized Medicine.” Trends in Pharmacological Sciences 24: 122–125.
  • Hair, J. F., R. E. Anderson, R. L. Tatham, and W. C. Black. 1992. Multivariate Data Analysis with Readings. New York: MacMillan.
  • Hair, J. F., C. M. Ringle, and M. Sarstedt. 2011. “PLS-SEM: Indeed a Silver Bullet.” Journal of Marketing theory and Practice 19 (2): 139–152.
  • Henseler, J., C. M. Ringle, and R. R. Sinkovics. 2009. “The use of Partial Least Squares Path Modeling in International Marketing.” Advances in International Marketing 20 (1): 277–319.
  • Herting, S. R. 2002. “Trust Correlated with Innovation Adoption in Hospital Organizations.” Am.Soc. Public administration’s 63rd National Conference, Phoenix, Arizona, March 8, 1–36.
  • Holland, S., and D. Stocks. 2017. “Trust and Its Role in the Medical Encounter.” Health Care Analysis 25 (3): 260–274.
  • Hoque, M. R., Y. Bao, and G. Sorwar. 2017. “Investigating Factors Influencing the Adoption of E-Health in Developing Countries: A Patient’s Perspective.” Informatics for Health and Social Care 42: 1–17.
  • Hwang, H. G., H. E. Han, K. M. Kuo, and C. F. Liu. 2012. “The Differing Privacy Concerns Regarding Exchanging Electronic Medical Records of Internet Users in Taiwan.” Journal of Medical Systems 36 (6): 3783–3793.
  • Jain, K. K. 2009. Textbook of Personalized Medicine (p. 186). New York: Springer.
  • James, L. R., and J. M. Brett. 1984. “Mediators, Moderators, and Tests for Mediation.” Journal of Applied Psychology 69 (2): 307.
  • Judd, C. M., and D. A. Kenny. 1981. “Process Analysis: Estimating Mediation in Treatment Evaluations.” Evaluation Review 5 (5): 602–619.
  • Karake Shalhoub, Z. 2006. “Trust, Privacy, and Security in Electronic Business: The Case of the GCC Countries.” Information Management & Computer Security 14 (3): 270–283.
  • Katsikas S, K., J. Lopez, and G. Pernul. 2005. “Trust, Privacy and Security in E-Business: Requirements and Solutions.” In Panhellenic Conference on Informatics, 548–558. Berlin, Heidelberg: Springer.
  • Kline, R. B. 2015. Principles and Practice of Structural Equation Modelling. Guilford.
  • Klugman, C. M., L. B. Dunn, J. Schwartz, and I. G. Cohen. 2018. “The Ethics of Smart Pills and Self-Acting Devices: Autonomy, Truth-Telling, and Trust at the Dawn of Digital Medicine.” The American Journal of Bioethics 18 (9): 38–47.
  • Kock, N. 2012. WarpPLS 3.0 User Manual. Laredo, TX: ScriptWarp Systems.
  • Krane, D., L. Light, and D. Gravitch. 2002. “Privacy On and Off the Internet: What Consumers Want”. Harris Interactive.
  • Kurti, L., and C. Tomiczek. 2017. “The Changing Landscape of the Genetic Counselling Workforce”, Final Report prepared for NSW Ministry of Health, URBIS.
  • Lee, V. 2017. “Transparency and Trust – Online Patient Reviews of Physicians.” New England Journal of Medicine 376 (3): 197–199.
  • Lee, M. K., and E. Turban. 2001. “A Trust Model for Consumer Internet Shopping.” International Journal of Electronic Commerce 6 (1): 75–91.
  • Leonard, K. J. 2004. “Critical Success Factors Relating to Healthcare’s Adoption of New Technology: A Guide to Increasing the Likelihood of Successful Implementation.” Electronic Healthcare 2: 72–81.
  • MacKinnon, D. P., A. J. Fairchild, and M. S. Fritz. 2007. “Mediation Analysis.” Annual Review of Psychology 58: 593–614.
  • Mali, P., L. Yang, K. Esvelt, J. Aach, M. Guell, J. E. DiCarlo, and G. M. Church. 2013. “RNA-Guided Human Genome Engineering via Cas9.” Science 339 (6121): 823–826.
  • Markus, M. L., S. Axline, D. Petrie, and S. C. Tanis. 2000. “Learning from Adopters’ Experiences with ERP: Problems Encountered and Success Achieved.” Journal of Information Technology 15 (4): 245–265.
  • Middleton, A., P. Marks, A. Bruce, L. K. Protheroe-Davies, C. King, O. Claber, C. Houghton, et al. 2017. “The Role of Genetic Counsellors in Genomic Healthcare in the United Kingdom: A Statement by the Association of Genetic Nurses and Counsellors.” European Journal of Human Genetics 25: 659–661.
  • Misra, S. C., and S. Bisui. 2014. “Critical Challenges for Adopting Personalized Medicine System in Healthcare Management, Perspectives of Clinicians and Patients.” International Journal of E-Health and Medical Communications 5 (2): 70–89.
  • Misra, S. C., and S. Bisui. 2016. “Feasibility of Large Scale Implementation of Personalized Medicine in the Current Scenario.” International Journal of E-Health and Medical Communications 7 (2): 30–49.
  • Misra, S. C., S. Bisui, and K. A. Fantazy. 2016. “Identifying Critical Changes in Adoption of Personalized Medicine (PM) in Healthcare Management.” International Journal of E-Health and Medical Communications 7 (3): 1–15.
  • Nagy, R., and A. C. Sturm. 2013. “Personalized Medicine: Impact on Patient Care in Genetic Counselling.” Current Genetic Medicine Reports 1: 129–134.
  • NHMRC. 2011. Clinical Utility of Personalised Medicine, Information for Health Professionals 2011. National Health and Medical Research Council, Australian Government. http://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/ps0001_clinical_utility_personalised_medicine_feb_2011.pdf.
  • Nunnally, J. C., and I. H. Bernstein. 1994. Psychometric Theory. New York, NY: McGraw Hill.
  • Oh, H., C. Rizo, M. Enkin, and A. Jadad. 2005. “What is EHealth (3): A Systematic Review of Published Definitions.” Journal of Medical Internet Research 7 (1): e1.
  • Ong, F. S., J. Z. Kuo, W. C. Wu, C. Y. Cheng, W. L. B. Blackwell, B. L. Taylor, and T. Y. Wong. 2013. “Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization.” Journal of Personalized Medicine 3 (1): 40–69.
  • PMC. 2007. “ Personalized Medicine: The Changing Landscape of Healthcare,” PMC. http://njms.umdnj.edu/genesweb2/documents/Personalized_Medicine.pdf.
  • PMC. 2010. “ Personalized Medicine 101: The Challenges.” http://www.personalizedmedicinecoalition.org/about/about-personalized-medicine/personalized-medicine-101/challenges.
  • PMC. 2014. “Personalized Medicine: An Introduction.” http://www.personalizedmedicinecoalition.org/sites/default/files/personalmed_backgrounder.pdf.
  • PMI. 2004. Project Management Body of Knowledge (PMBOK). 3rd ed. Pennsylvania: Project Management Institute.
  • Pritchard, D. E., Franziska Moeckel, Mary Susan Villa, Laura T. Housman, Catherine A. McCarty, and Howard L. McLeod. 2017. “Strategies for Integrating Personalized Medicine Into Healthcare Practice.” Personalized Medicine 14: 141–152.
  • Sánchez, J. L., S. Savin, and V. Vasileva. 2005. “Key Success Factors in Implementing Electronic Medical Records in University Hospital of Rennes”. L’EcoleNationale de la Santé Publique (National School of Public Health), Rennes, Rennes, France, 1–59.
  • Schumacker, R. E., and R. G. Lomax. 2004. A Beginner’s Guide to Structural Equation Modelling. London: Psychology Press.
  • Schwaber, K., and M. Beedle. 2002. Agile Software Development with Scrum. Vol. 1. Upper Saddle River: Prentice Hall.
  • Schwartz, E. J., and A. M. Issa. 2017. “The Role of Hospital Pharmacists in the Adoption and Use of Pharmacogenomics and Precision Medicine.” Personalized Medicine 14: 27–35.
  • Stokes, M. E., C. S. Davis, and G. G. Koch. 2012. Categorical data Analysis using SAS. SAS institute.
  • Sun, H., and P. Zhang. 2006. “The Role of Moderating Factors in User Technology Acceptance.” International Journal of Human-Computer Studies 64: 53–78.
  • Triplett, S. M., and, J. M. I. Loh. 2018. “The Moderating Role of Trust in the Relationship Between Work Locus of Control and Psychological Safety in Organisational Work Teams.” Australian Journal of Psychology 70: 76–84.
  • UOU. 2013. “ Challenges and Issues in Personalized Medicine and Pharmacogenetics.” http://learn.genetics.utah.edu/content/health/pharma/issues/.
  • van der Smagt, T. 2000. “Enhancing Virtual Teams: Social Relations v. Communication Technology.” Industrial Management & Data Systems 100 (4): 148–156.
  • Vorderstrasse, A. A., M. J. Hammer, and J. R. Dungam. 2014. “Nursing Implications of Personalized and Precision Medicine.” Seminars in Oncology Nursing 30: 130–136.
  • Wideroff, L., A. N. Freedman, L. Olson, C. N. Klabunde, W. Davis, K. P. Srinath, and R. Ballard-Barbash. 2003. “Physician Use of Genetic Testing for Cancer Susceptibility Results of a National Survey.” Cancer Epidemiology Biomarkers & Prevention 12 (4): 295–303.
  • Wiener, C., P. Thomas, E. Goodspeed, D. Valle, and D. G. Nichols. 2010. “‘Genes to Society’– The Logic and Process of the New Curriculum for the John Hopkins University School of Medicine.” Academic Medicine 85: 498–506.
  • Zamft, B., A. H. Marblestone, K. Kording, D. Schmidt, D. Martin-Alarcon, K. Tyo, and G. Church. 2012. “Measuring Cation Dependent DNA Polymerase Fidelity Landscapes by Deep Sequencing.” PloS one 7 (8): e43876.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.